- A Novel Method for Quantitative Detection of Purines and Their Metabolites (SJ-13-0014)
- AML MRD Markers (SJ-18-0011)
- Assay for Detecting ALK Inhibitor Resistance Mutations (SJ-09-0042)
- Association of Neuraminidase Regulated Exocytosis with Cancer Metastasis (SJ-11-0012)
- CHANGE-seq: a rapid, high-throughput method to define genome-wide activity of CRISPR-Cas genome editors (SJ-18-0041)
- Detecting TERT Promoter Methylation for Cancer Diagnosis (SJ-16-0015)
- Determining CAR T Cell Effectiveness (SJ-19-0040)
- Genotyping Assay to Predict CYP3A5 Phenotype (SJ-01-0005)
- Medulloblastoma Subtyping Assay (SJ-10-0020)
- Methods for Diagnosing and Treating Learning or Mental Disorders with the SERCA2 Protein and miRNAs that regulate SERCA2 Levels (SJ-10-0003 and SJ-12-0020)
- New Markers for Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia (SJ-11-0025)
- Rapid Cloning of T Cell Receptors (SJ-16-0001)
- XAF-1 Mutations Linked to Cancer Susceptibility (SJ-15-0016)